Wednesday, March 09, 2005

Early Release Article from New England Journal of Medicine

"Intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD provides significant clinical benefit beyond that afforded by treatment with 10 mg of atorvastatin per day. This occurred with a greater incidence of elevated aminotransferase levels." [NEJM -- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease]